Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%

May.08
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.

Key Takeaways

  • Turning Point Brands reported first-quarter 2026 total consolidated net sales of $124.3 million, up 16.8%.
  • Modern Oral net sales increased 133% to $52.0 million, accounting for 42% of total company net sales.
  • Stoker’s segment net sales rose 48.1% to $87.6 million, accounting for 70% of quarterly net sales.
  • Zig-Zag segment net sales declined 22.4% to $36.7 million, accounting for 30% of quarterly net sales.
  • The company raised full-year Modern Oral net sales guidance to $210 million to $225 million, from $180 million to $190 million.

2Firsts, May 8, 2026

 

According to Turning Point Brands, Inc.’s first-quarter 2026 earnings release, the company reported total consolidated net sales of $124.3 million for the quarter ended March 31, 2026, up 16.8% year on year. Gross profit increased 14.6% to $68.3 million. 

 

Net income declined 19.0% to $11.7 million, while adjusted EBITDA decreased 6.5% to $25.9 million. Diluted EPS was $0.60 and adjusted diluted EPS was $0.76, compared with $0.79 and $0.91, respectively, in the same period a year earlier.

 

Modern Oral net sales increased 133%

 

The company said Modern Oral net sales increased 133% to $52.0 million in the first quarter of 2026, accounting for 42% of total company net sales, up from 21% in the first quarter of 2025.

 

Company raised full-year Modern Oral guidance

 

For 2026, Turning Point Brands raised its Modern Oral sales guidance. 

 

The company now expects full-year Modern Oral gross sales of $280 million to $300 million, up from previous guidance of $220 million to $240 million.

 

 It expects full-year Modern Oral net sales of $210 million to $225 million, up from $180 million to $190 million. 

 

The company also introduced full-year adjusted EBITDA guidance of $70 million to $90 million, inclusive of investments in Modern Oral sales, marketing and trade promotions.

 

CEO said Q1 was driven by Modern Oral momentum

 

President and CEO Graham Purdy said the first quarter was driven by continued momentum in Modern Oral and disciplined execution across the portfolio. He said the company is investing in brands, commercial capabilities and consumer reach to capture share in white pouch, including through its recently announced TKO partnership featuring UFC.

 

Stoker’s segment net sales increased 48.1%

 

Stoker’s products segment net sales were $87.6 million in the first quarter, up 48.1% year on year and representing 70% of total quarterly net sales. The company said the increase was driven by triple-digit growth in Modern Oral net sales. Segment gross profit increased 39.1% to $47.3 million. Gross profit as a percentage of net sales fell to 54.0% from 57.5% a year earlier, primarily driven by margin contribution from Modern Oral products.

 

Zig-Zag segment net sales decreased 22.4%

 

Zig-Zag products segment net sales were $36.7 million, down 22.4% year on year and representing 30% of total quarterly net sales. The company said the decline was driven primarily by lower U.S. papers and wraps shipments. 

 

Segment gross profit decreased 18.1% to $20.9 million. Gross profit as a percentage of net sales rose to 57.1% from 54.1% a year earlier, driven primarily by product mix.

 

Sales and marketing investments increased SG&A expenses

 

The company said first-quarter investment focused on sales and marketing efforts to support distribution and brand building. 

 

Consolidated selling, general and administrative expenses increased 53.2% year on year to $55.8 million, including Modern Oral-related sales and marketing investments and increased outbound freight costs.

 

Ending cash was $192.4 million

 

As of March 31, 2026, ending cash was $192.4 million and net debt was $101.4 million. The company ended the quarter with total liquidity of $265.0 million, comprising $192.4 million in cash and $72.6 million of asset-backed revolving credit facility capacity.

 

Financial statements showed lower operating income

 

According to the consolidated statements of income on page 5 of the release, operating income was $12.5 million in the first quarter of 2026, compared with $23.2 million in the first quarter of 2025. Net income attributable to Turning Point Brands, Inc. was $11.7 million, compared with $14.4 million a year earlier.

 

Operating cash flow turned negative

 

According to the cash flow statement on page 7 of the release, the company used $22.3 million in cash from operating activities in the first quarter of 2026, compared with $17.4 million provided by operating activities in the same period of 2025. During the period, inventories increased by $21.7 million and accrued liabilities and other items decreased by $21.7 million.

 

Adjusted EBITDA was $25.9 million

 

According to Schedule A on page 9, adjusted EBITDA was $25.9 million in the first quarter of 2026, compared with $27.7 million in the same period of 2025. 

 

Adjustments included a $5.9 million tariff adjustment, $2.9 million in stock-based compensation, $0.6 million in manufacturing start-up costs and $0.3 million in FDA PMTA-related costs.

 

Adjusted net income was $14.8 million

 

According to Schedule B on page 10, adjusted net income was $14.8 million in the first quarter of 2026, and adjusted diluted EPS was $0.76. In the first quarter of 2025, adjusted net income was $16.7 million and adjusted diluted EPS was $0.91.

 

Company said products are available in more than 220,000 retail outlets

 

Turning Point Brands said it manufactures, markets and distributes branded consumer products including alternative smoking accessories and consumables with active ingredients. Its brand portfolio includes Zig-Zag, Stoker’s, FRE and ALP. 

 

The company said its products are available in more than 220,000 retail outlets in North America and on sites including zigzag.com, frepouch.com and alppouch.com.

 

Image Source: Turning Point Brands

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03